We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Tissue Characterization to Diagnose Prostate Cancer

By MedImaging International staff writers
Posted on 25 Aug 2010
New innovative and proprietary tissue characterization technology has been designed to differentiate, characterize, and visualize solid organ tissue types based on the analysis of backscattered ultrasound. It was designed to support physicians in diagnosis and treatment decisions.

Advanced Medical Diagnostics SA (AMD; Waterloo, Belgium), a privately held company focused on providing innovative computer-aided solutions (HistoScanning) that can improve the diagnostic interpretation of ultrasound scans, announced that it has appointed BK Medical UK, Ltd. as sole agent for Prostate HistoScanning in the United Kingdom.

Prostate HistoScanning, available in Europe, may support the diagnosis and management of prostate cancer. HistoScanning products for breast, thyroid, and ovaries are in development. Advanced Medical Diagnostics SA and BK Medical UK, Ltd. (Herlev; www.bkmed.com) have been working closely together since the commercial launch of Prostate HistoScanning in November 2008. These systems have been placed in four major teaching hospitals in the United Kingdom, most recently at Guys Hospital and Charing Cross Hospital in London.

As agents, BK Medical Limited will be responsible for the day-to-day management of sales and for providing service support for UK customers. Over the last 18 months, BK has been instrumental in placing over 20 Prostate HistoScanning systems alongside the BK Pro Focus and Pro Focus UltraView ultrasound systems in leading urology departments across Europe.

Toby Hamblin, VP sales of AMD, commented, "BK Medical, with its strong base in ultrasound urology in the UK, is very well placed to help us realize the full potential of Prostate HistoScanning and to provide the NHS and private clinics alike with the service and support that they, and this exciting new technology, deserve. We are very pleased to have the support of BK Medical in this important market.”

HistoScanning has not yet received market clearance by the U.S. Food and Drug Administration for commercial use in the United States.

Related Links:
Advanced Medical Diagnostics
BK Medical UK


X-ray Diagnostic System
FDX Visionary-A
MRI System
nanoScan MRI 3T/7T
Pocket Fetal Doppler
CONTEC10C/CL
Adjustable Mobile Barrier
M-458

Channels

General/Advanced Imaging

view channel
Image: Example snapshots of the photon energy density at t = 0.5, 0.7, 0.9, 1.1 nanoseconds (ns) on the y = 2.0 cm plane (Horie, S., Yajima, H., Abe, M. et al., Biomedical Engineering Letters (2026). DOI: 10.1007/s13534-026-00578-9)

AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection

Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.